跳至主要内容
临床试验/NCT02484157
NCT02484157已完成不适用

Comparison of Activated Coagulation Time Between Hemochron Jr and ACT Plus During Cardiac Surgery for Patient Using Acute Normovolemic Hemodilution

Hallym University Medical Center2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
2
主要终点
Comparison of activated coagulation time between Hemochron Jr and ACT Plus

研究概览

简要总结

This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).

详细描述

Measurement of activated clotting time (ACT) is a standard method for anticoagulation monitoring. Especially in cardiac surgery, heparin is usually used as anticoagulant and protamine is used to reverse anticoagulation effect at the end of surgery. ACT method defines the time until a clot is formed in a test tube after triggering of internal pathway coagulation using blood activating agents (eg. kaolin).

Acute normovolemic hemodilution (ANH) consists of withdrawing patient's blood volume early in the operative period and concurrent infusion of crystalloid or colloid to maintain intravascular volume, and is used in cardiac surgery. ANH is known to affect hemostasis in some studies.

Assuming that accurate monitoring of coagulation therapy is important to prevent both thrombotic and hemorrhagic complications, we compared ACT results from 2 analysers (Hemochron Jr and ACT Plus) in patients undergoing cardiac surgery using ANH.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who underwent cardiac surgery with heparin administration.

排除标准

  • Preoperative hemoglobin under 11g/dL
  • Weight under 40kg
  • Preoperative coagulopathy

结局指标

主要结局

Comparison of activated coagulation time between Hemochron Jr and ACT Plus

时间窗: During cardiac surgeris (within 8 hours)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验